Premium
Hypothalamic mass and gigantism in neurofibromatosis: Treatment with bromocriptine
Author(s) -
Duchowny Michael S.,
Katz Raananah,
Bejar Rafael L.
Publication year - 1984
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410150318
Subject(s) - gigantism , bromocriptine , acromegaly , neurofibromatosis , medicine , endocrinology , lesion , growth hormone , prolactin , surgery , pathology , hormone
A child with neurofibromatosis exhinbited gigantism and acromegaly in association with a hypothalamic mass lesion. Bromocriptine, 5 mg daily, reduced somatic growth rate and restored biochemical mohesostasis but had no effect on tumor grwoth. Radiation therapy arrested tumor enlargement and stabilized deeriorating visual function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom